Atypical Parkinson's syndromes

   

Compiled by Andreas Tews, CEO of the German PSP Society

WHAT IS PSP?

psp cartoonPSP is a rare neurodegenerative brain disease. It describes a brain dysfunction caused by tau protein clumping. It is estimated that around six to seven out of 100.000 people will develop PSP at some point in their lives. PSP occurs predominantly from the age of 40 onwards.

PSP was discovered in 1963 by Dr. John C Steele, Dr. JC Richardson and Dr. J.Olszewski. PSP is closely related to Parkinson's disease, making it difficult to diagnose. In many cases, the patient has to odyssey through medical practices and clinics until the correct diagnosis is made - often years later.

So far there is no cure for the disease, only a few drugs can alleviate the symptoms.

Research into PSP is currently making great progress. An international working group led by Prof. Höglinger has developed new diagnostic criteria early detection developed. New therapies are being tested. Dr. Gesine Respondek from the Neurocenter of the Technical University of Munich and member of the German Study Group on Atypical Parkinson's Syndromes has identified five different forms (PSP phenotypes).

PSP phenotypes (progressive forms)

The symptoms that patients with PSP suffer from at the onset of the disease can vary greatly. There is a typical progression that was first described in 1963 and is now called the Richardson symptom after the person who first described it. This progressive form of PSP has very typical symptoms. It is not usually confused with other diseases. However, some patients develop the symptoms that are important for the PSP diagnosis only late or not at all. In these progressive forms, the disease is not recognized as PSP until late in many of those affected. The different forms of PSP are also referred to as PSP phenotypes and are described below.

Typical course forms

PSP Richardson Syndrome (PSP-RS)

In the typical form, a characteristic supranuclear gaze palsy develops, which is manifested by limitations in the ability to look up or down at will. Gait is often unsteady and unsteady early in the course of the disease, with a tendency to fall backwards (postural instability). There is increasing stiffening of the muscles (rigor), with the neck and trunk being more affected than the arms and legs. Patients are often only able to sit, stand and walk upright. All movements are slowed down (bradykinesis). Some sufferers can only speak slurred (dysarthria). Difficulty swallowing (dysphagia) is also common. In addition, there may be a reduction in attention, deficits in the planning of actions and changes in personality, such as increased aggression, disinhibited behavior and reduced drive.

Atypical progression forms

There are other forms of PSP progression. They are named after their clinical picture, which is in the foreground at the beginning of the disease. Often the symptoms are similar to those of other diseases, making it difficult for the doctor to make the correct diagnosis. In the further course, however, symptoms can also occur that are typical of Richardson's symptoms.

PSP – Parkinsonism (PSP-P)

In this form, the main signs of Parkinsonism are a slowing of movement (bradykinesia) and a stiffening (rigor). Sometimes tremors can also occur. Patients can initially take one Therapy L-Dopa provides relief from symptoms. This makes it difficult to distinguish the symptoms in the early stages from Parkinson's disease. After more than 2 years, patients can also develop the symptoms of classic PSP. (Richardson syndrome) =: postural instability and supranuclear palsy.

PSP akinesia with gait blockages (PSP-PGF)

This progressive form begins with gait disturbances (slow or unsteady gait) accompanied by "freezing" of the gait and speech. Here, too, the patients only develop the symptoms of classic PSP later. Tremor, rigidity, bradykinesia and memory impairment do not appear in the first 5 years.

PSP – Corticobasal Syndrome (PSP-CBS)

In this form of the disease, the symptoms are accentuated or appear exclusively on one side of the body. Disturbance of the coordination of action sequences (apraxia), involuntary muscle twitching (myoclonus), sensory disturbances of the skin (cortical loss of sensitivity), incorrect posture of the limbs (dystonia) and Parkinson-like symptoms such as rigidity and bradykinesia can occur. At the same time or later, the symptoms of classic PSP develop.

PSP – PSP with speech/speech disorders (PSP-SL)

Speech coordination disorders (speech apraxia), lack of grammatical structures (agrammatism) and distorted speech sounds (sound positions) are the main features of this progression. Bradykinesis, postural instability, and supranuclear palsy develop later.

PSP – the main symptoms

Symptoms can vary greatly from person to person!

However, some abnormalities are observed particularly frequently.

The main symptom is a progressive limitation of voluntary eye movements - this can include:

  • Unsteady gait and dizziness
  • Falls “out of the blue”, especially backwards
  • Difficulty walking, balance problems
  • Slowing down of movements, similar to Parkinson's disease
  • Vision problems, such as double vision or blurred vision
  • speech and swallowing problems
  • sleep disorders
  • Drive impoverishment, personality change

 

Symptoms that often lead to the diagnosis of PSP are falling, especially backwards, and an increasing inability to lower your eyes.

 

dr medical Gesine Respondek and Prof. Dr. medical Günter Höglinger,
Neurology Clinic, Klinikum Rechts der Isar, Technical University of Munich
and German Center for Neurodegenerative Diseases Munich

WHAT IS MSA?

msa cartoonMSA is a rare neurodegenerative disease characterized by continuous loss of nerve cells in certain areas of the brain. Despite intensive research, the cause of the death of the nerve cells is still unclear. In Germany, about two to five per 100.000 inhabitants contract MSA. The mean age at onset is between 50 and 60 years. Men and women are affected about equally often.

Symptoms

Symptoms of MSA include a movement disorder in combination with a dysfunction of the autonomic nervous system, e.g. B. by a disorder of bladder function, erectile function, intestinal motility or the regulation of blood pressure and body temperature.

A distinction is made between two variants of MSA: MSA-P with predominantly Parkinson's-like symptoms, which are reflected in slowing movement and stiffness of the muscles - and MSA-C, a functional disorder of the cerebellum with increasing balance disorders, uncoordinated movements (ataxia), which Poor posture, walking, standing and movement of the extremities, along with difficulties in speaking and swallowing. Other symptoms can also occur, such as wheezing when breathing in and breathing stops at night.

Other symptoms of MSA can include involuntary tightening of the muscles in the face or trunk, and poor posture of the trunk, hands, or feet. Many MSA patients also have what is known as REM sleep behavior disorder. Those affected report very vivid and sometimes aggressive dreams. The relatives observe that these dreams are acted out during sleep in the form of complex and targeted movements due to the lack of relaxation of the muscles. These symptoms can vary greatly from person to person. Typically, patients have some of the above symptoms, sometimes in combination; rarely all symptoms are present in one patient.

Symptom relief

Unfortunately, no therapy is currently available that can slow down or stop the progression of the disease. Only the symptoms can be partially alleviated by various medications and therapies. Approximately 80% of MSA-P patients show an initial improvement in slowed movements and insecure gait through the use of levodopa therapy. The effect is usually temporary. So far there are no therapy options for the treatment of cerebellar dysfunction.

Further measures

It is particularly important to carry out regular physiotherapeutic and ergotherapeutic measures. This is intended to preserve as much independence as possible, prevent falls and delay increasing immobility.

 

PD. dr medical Johannes Levin, Neurological Clinic,
movement disorders clinic,
Ludwig-Maximilians-University of Munich, Clinic of the University of Großhadern

WHAT IS CBD?

cbd cartoonLike PSP and MSA, CBD is a rare neurodegenerative disease characterized by continuous loss of nerve cells in certain areas of the central nervous system. Approximately one in 100.000 people will develop CBD. The mean age at onset is in the 6th and 7th decade of life. Men and women are affected about equally often. There are currently no cures.

Disease symptoms

All patients have symptoms caused by nerve cell death in the population of nerve cells deep in the brain (basal ganglia) in addition to symptoms caused by nerve cell death in the cortex. Hence the name "cortico (cortex = cerebral cortex) basal (basal ganglia) degeneration (= loss of nerve cells)". These symptoms are usually very asymmetrical, ie they are much more pronounced on one side of the body than on the other side. Neuronal cell death in the basal ganglia causes Parkinson's-like symptoms such as muscle stiffness and slow movement. Neuronal cell death in the cerebral cortex causes disturbances in the execution of voluntary actions and the use of tools despite adequate motor function. This is referred to as "apraxia". In addition, sensory disturbances, which become noticeable when touching objects with closed eyes, can occur (cortical sensory disturbance). Another symptom, experiencing an arm or leg as not belonging to one's own body, has the characteristic name "alien limb phenomenon". In addition, behavioral disorders in the form of disinhibition, apathy or increased irritability and also speech and language disorders can occur. In addition, there are characteristic symptoms, such as an involuntary tensing of the arm muscles on the affected side with the resulting incorrect bending of the elbow and wrist. The patients also show myoclonus, as involuntary, jerky twitching of individual muscle groups. Trembling of an arm or leg, which often has an irregular and jerky effect due to superimposition with the myoclonus mentioned, can also occur. As the disease progresses, many patients become increasingly immobile and in need of care.

Symptom relief

There is currently no therapy option to slow down the progression of CBD. If necessary, drug therapy can alleviate the symptoms of CBD. The fact that around 30 percent of patients show an improvement, albeit often only temporary, in their slow movements and unsteady gait with levodopa justifies a therapy attempt. Many patients with a CBD also suffer from a depressive disorder. This should be recognized as early as possible and treated appropriately.

CBD disease is now also known as corticobasales syndrome (CBS).

 

PD. dr medical Johannes Levin, Neurological Clinic,
movement disorders clinic,
Ludwig-Maximilians-University of Munich, Clinic of the University of Großhadern

Stay tuned.


0 Comments

Leave a comment

Participate in the discussion?
Leave us your comment!

Would you like to comment on the article or add something?

This website uses Akismet to reduce spam. Learn more about how your comment data is processed.

PHP code snippets Powered By: XYZScripts.com